MedPath

Comparison of ER:YAG Laser, CO2 Laser and Scalpel Excision of Fibrous Hyperplasia on the Buccal Mucosa

Not Applicable
Completed
Conditions
Fibrous Hyperplasia on Oral Mucosa
Interventions
Procedure: Excisional biopsy with CO2 laser
Procedure: Excisional biopsy with scalpel
Registration Number
NCT03001791
Lead Sponsor
University of Bern
Brief Summary

The aim of the RCT is to analyse clinical and histopathological particularities for excisional biopsies of fibrous hyperplasia in the buccal mucosa performed with Er:YAG laser, CO2 laser and scalpel. The primary outcome parameter is to evaluate the thermal damage zone on the excised specimens. Secondary parameters are time of surgery, intraoperative bleeding, the need for additional electrocoagulation or sutures and patient's postsurgical perception of pain, other postsurgical effects and use of analgesics.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Clinical tentative diagnosis of fibrous hyperplasia in the buccal mucosa
  • Fibrous hyperplasia dimensions 0.5 to 2 cm
  • Patient understands and reads the German language
  • Written informed consent
Exclusion Criteria
  • Untreated diabetes Typ II
  • Severe infectious disease (HIV, hepatitis)
  • Severe psychiatric disease
  • Immunosuppressive therapy
  • Anticoagulation
  • Pregnancy; a pregnancy test (Clearblue®) is performed in women of childbearing age

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CO2 laserExcisional biopsy with CO2 laserExcisional biopsy of fibrous hyperplasia with CO2 laser (Spectra DENTA Surgical Carbon Dioxide Laser, MAX Engineering Ltd., Gyeonggi-Do, Korea), λ = 10'600nnm. cf mode (frequency 140 Hz, pulse duration 400 µsec, pulse energy 33 mJ,a power 4.62 watts). Laser beam with a spot size of 0.2 mm, non-contact mode.
ScalpelExcisional biopsy with scalpelExcisional biopsy of fibrous hyperplasia with scalpel (blade 15C). Polyamide sutures (Seralon 5-DS15, Serag Wiessner KG, Naila, Germany).
Primary Outcome Measures
NameTimeMethod
Histopathological thermal damage zoneThree months

Biopsy specimens fixed in a 4% neutral-buffered formalin solution, embedded in paraffin, sectioned in slices of 5 μm, and stained with hematoxylin-eosin.

Measurements of the thermal damage zone (in μm) on histopathological specimens by pathologist, blinded to the surgical method used. Measurements of the maximal and the minimal thermal damage zone on a representative section on both lateral edges of the fibrous hyperplasia.

Secondary Outcome Measures
NameTimeMethod
Number of patients with other postoperative effectsTwo weeks

Number of patients with other postoperative events (e.g. swelling, bleeding) on the same study form

Time of surgery15 minutes

Registration of time of intervention with a stopwatch. It starts when the laser beam is first applied and ends when the wound paste had been applied.

Postoperative PainTwo weeks

Registration of pain on VAS scale (ranging 0-100) during 14 days. The first VAS value was filled in before surgery, the second value in the evening after surgery and then on each of the following days on a study form handed out to patient.

Intake of Analgesic (type, dose) are also filled in by patient on the study form i a specific section.

Bleeding during surgery15 minutes

Registration of bleeding events (yes/no) and method to stop the bleeding during surgery (electrocautery, sutures)

Trial Locations

Locations (1)

Department of oral Surgery and Stomatology, Dental school, University Bern

🇨🇭

Bern, Switzerland

© Copyright 2025. All Rights Reserved by MedPath